AdooQ BioScience
AdooQ BioScience is a privately held US supplier of research-grade biochemicals — including inhibitors, chemical probes, PROTACs, ADCs, and recombinant proteins — operating a global e-commerce catalog of 60,000+ products serving academic researchers and pharmaceutical companies.
- Company typePrivate
- Founded2006
- HeadquartersIrvine, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What AdooQ BioScience does
AdooQ BioScience (legal entity: Adooq Bioscience LLC) is a privately held US supplier of research-grade biochemicals headquartered in Irvine, California. Founded in 2006, the company operates a direct-to-consumer e-commerce catalog platform selling high-purity inhibitors, chemical probes, reference compounds, recombinant proteins, PROTACs, antibody-drug conjugates (ADC), nanobodies, biosimilar antibodies, peptides, dyes, click chemistry reagents, CRISPR reagents, isotope-labeled compounds, and liposome formulations. Its 60,000+ product catalog is organized primarily by signaling pathway (Epigenetics, Apoptosis, PI3K/Akt/mTOR, Tyrosine Kinases, GPCR/G Protein, MAPK, JAK/Stat, Metabolism, Cell Cycle, DNA Damage, Angiogenesis) and targets research areas spanning cancer, immunology, neuroscience, epigenetics, and stem cell biology.
The underlying technology is a curated biochemical product catalog rather than a software or services platform; differentiation rests on catalog breadth, product purity specifications, ordering convenience, and accumulated scientific-credibility signals (over 20,000 peer-reviewed citations including top-tier publications such as Science, Cell, and Nature, plus more than 100 patent applications covering proprietary compounds). The company does not publish a developer-facing API and operates as a traditional B2B/B2C e-commerce storefront with login-gated pricing and free sample requests. Pricing is unit-based, pay-as-you-go, and not publicly disclosed — it requires account creation to view.
AdooQ's go-to-market is primarily direct e-commerce via adooq.com, supplemented by a global distributor network supporting multi-currency checkout (USD, AUD, GBP, CAD, EUR). Customer segmentation is horizontal: academic and institutional research is the primary segment, with pharmaceutical and biotechnology drug-discovery teams as the secondary segment. Marketing channels are predominantly digital — an email newsletter for product launches, search-optimized e-commerce listings, and reliance on organic citation-driven credibility — with distributors extending international reach. Revenue figures, funding history, ownership structure, management team composition, and M&A activity are not publicly disclosed, representing material data gaps for any external investor assessment.
AdooQ BioScience firmographics
Firmographics- Name
- AdooQ BioScience
- Legal name
- Adooq Bioscience LLC
- Website
- https://adooq.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- AdooQ BioScience is a privately held US supplier of research-grade biochemicals — including inhibitors, chemical probes, PROTACs, ADCs, and recombinant proteins — operating a global e-commerce catalog of 60,000+ products serving academic researchers and pharmaceutical companies.
- Ownership category
- akta.pro rank
AdooQ BioScience industry classification
Industry- Product category
- Life Science Research Biochemicals
- NAICS
- Medicinal and Botanical Manufacturing (325411)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
- akta.pro secondary industries
- Antibody-Drug Conjugates (ADCs) & Antibody Conjugates (HLAAAAAE), Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB)
Keywords
Where AdooQ BioScience is headquartered
LocationHeadquarters
- HQ city
- Irvine
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
AdooQ BioScience business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Operations, Personnel, Marketing or Sales, Infrastructure
Revenue model
- Research Biochemical Products: AdooQ generates revenue through the sale of high-purity inhibitors, chemical probes, reference compounds, and related research biochemicals. Products are sold individually with unit pricing through their e-commerce platform, serving the global scientific research community with over 60,000 catalog products.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Standard catalog product pricing |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
AdooQ BioScience product offering
Product offeringCore offering
AdooQ BioScience manufactures and distributes a catalog of more than 60,000 high-purity research biochemicals, including inhibitors, chemical probes, and reference compounds organized by signaling pathway. The company sells these products directly to research scientists and institutions through its e-commerce platform at adooq.com, with global distribution and multi-currency checkout. The portfolio extends to PROTACs, antibody-drug conjugates, recombinant proteins, peptides, dyes, click chemistry reagents, isotope-labeled compounds, nanobodies, CRISPR reagents, and screening libraries used in academic and pharmaceutical drug discovery research.
Product overview
AdooQ Bioscience is a research biochemical supplier founded in 2006, operating as an e-commerce platform that offers over 60,000 catalog products. The core offering consists of bioactive compounds (inhibitors, chemical probes, and reference compounds) organized by signaling pathways including Epigenetics, Apoptosis, PI3K/Akt/mTOR, Protein Tyrosine Kinases, GPCR/G Protein, MAPK, JAK/Stat, and others. The portfolio includes specialized product types such as PROTACs (Proteolysis-Targeting Chimeras) with various degrader and linker variants, Antibody-drug Conjugates (ADC), Nanobodies, Biosimilar Antibodies, Peptides, Dyes, Click Chemistry reagents, Natural Products, Isotope-Labeled Compounds, and Liposome formulations. Supporting product lines include Screening Libraries, a comprehensive Proteins catalog (recombinant proteins, neurotrophins, growth factors, antibodies, cytokines), and general Bioreagents. Products serve research areas spanning Cancer, Cardiovascular, Endocrinology, Epigenetics, Immunology, Signal Transduction, Metabolism, Neuroscience, PROTAC, Stem Cell, and Transmembrane research.
Differentiator
Problem solved
Functional benefit
Products and services
- Bioactive Compounds High-purity inhibitors, chemical probes, and reference compounds for research applications, covering signaling pathways including Epigenetics, Apoptosis, PI3K/Akt/mTOR, Protein Tyrosine Kinases, GPCR/G Protein, MAPK, JAK/Stat, Metabolism, Cell Cycle, DNA Damage, and others. Target users are academic and pharmaceutical researchers.
- Screening Libraries Collections of compounds designed for high-throughput screening applications in drug discovery research, intended for pharmaceutical and biotechnology discovery teams.
- Proteins Recombinant proteins including neurotrophins, polyclonal antibodies, growth factors, hormones, monoclonal antibodies, natural proteins, viral antigens, CD antigens, chemokines, enzymes, and cytokines for research applications.
- Bioreagents General laboratory bioreagents supporting life science research workflows for academic and pharma laboratories.
- PROTACs (Proteolysis-Targeting Chimeras) Heterobifunctional degraders including E3 Ligase Ligand-Linker Conjugates, PROTAC Degraders, PROTAC Linkers, Molecular Glues, SNIPERs, and Target Protein Ligand-Linker Conjugates for targeted protein degradation research.
- Antibody-drug Conjugates (ADC) ADC payloads (cytotoxins), linkers, drug-linker conjugates, and antibody-drug conjugates for cancer research and targeted therapy development.
- Nanobodies Recombinant VHHs, nano-secondary antibodies, and tag nano-antibodies for research applications.
- Biosimilar Antibodies Research-grade recombinant antibodies designed to resemble approved therapeutic antibodies for drug discovery and pharmacological studies.
- Peptides Research peptides for various biological applications including peptide-based drugs and research reagents.
- Dyes Fluorescent and other dyes for research and diagnostic applications.
- Click Chemistry Reagents Click chemistry building blocks including Azide, Alkyne, DBCO, TCO, Tetrazine, and BCN compounds for bioconjugation research.
- Natural Products Naturally-derived compounds for research applications.
- Isotope-Labeled Compounds Isotope-labeled research compounds for metabolic studies and analytical applications.
- Liposome Liposomal formulations and components for drug delivery research.
- CRISPR Reagents Reagents for CRISPR gene editing research applications.
- COVID-19 Related Products Products related to COVID-19 research including SARS-CoV related compounds.
Quantifiable outcome
- Products validated in 20,000+ peer-reviewed publications including top-tier journals
Companies that use AdooQ BioScience
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
AdooQ BioScience technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AdooQ BioScience partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Distributor NetworkcoreAdooQ maintains a global network of distributors to extend their market reach internationally, supporting multiple currencies and regions.
Scale indicators4 records
Recent moves5 records
Expansion highlights5 records
AdooQ BioScience competitors and assessment
Company assessmentDirect peers
- Santa Cruz Biotechnology: Santa Cruz Biotechnology supplies antibodies, biochemicals, lab reagents, and research tools via direct e-commerce to academic researchers. It overlaps with AdooQ in bioreagents, antibodies, and inhibitor offerings targeting similar customers.
- Cayman Chemical: Cayman Chemical is a long-established supplier of research biochemicals, including inhibitors, prostaglandins, and assay kits for life science research. It overlaps with AdooQ in high-purity research compounds and serves similar academic and pharma customers.
- MedChemExpress (MCE): MCE is a leading global e-commerce supplier of small-molecule inhibitors, chemical probes, and reference compounds for life science research. It directly competes with AdooQ in the same DTC inhibitor/probe catalog model serving academic and pharma drug-discovery researchers.
- Tocris Bioscience (Bio-Techne): Tocris supplies high-purity life science research reagents, including inhibitors and probes focused on neuroscience and signaling pathways. As a Bio-Techne subsidiary, it competes with AdooQ in catalog biochemicals with deeper scientific content and brand recognition.
- TargetMol Chemicals: TargetMol supplies inhibitor libraries, natural compounds, and reference standards through an e-commerce platform targeting drug discovery researchers. It directly competes with AdooQ in catalog-based biochemical sales, particularly in screening libraries and natural products.
- APExBIO: APExBIO is an e-commerce-focused supplier of inhibitors, screening libraries, PROTACs, and biochemical reagents serving academic and pharma researchers. It competes head-to-head with AdooQ in catalog breadth and DTC pricing.
- Enzo Life Sciences: Enzo Life Sciences manufactures and distributes a broad catalog of life science research reagents, including enzymes, antibodies, and small-molecule probes. It competes with AdooQ in offering integrated reagent portfolios to academic and pharma research customers.
- Selleck Chemicals: Selleck is a major online supplier of high-purity inhibitors, agonists, and research compounds organized by signaling pathway—directly overlapping AdooQ's core product taxonomy and customer base. Both compete on catalog breadth, citations, and DTC fulfillment.
Broad incumbents
- Sigma-Aldrich (MilliporeSigma / Merck KGaA): Sigma-Aldrich is the largest global supplier of life science reagents, chemicals, and analytical standards. It competes broadly with AdooQ across almost every research compound category but at vastly greater scale, distribution, and brand recognition.
- Bio-Techne: Bio-Techne is a large, publicly traded life-science tools company owning R&D Systems, Tocris, and Novus Biologicals. It offers an overlapping portfolio of proteins, antibodies, and small-molecule reagents across the same research customers as AdooQ, with deeper scientific content and commercial infrastructure.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
AdooQ BioScience social profiles
Digital presenceAdooQ BioScience financial estimates
Financial estimateRevenue estimate
Valuation estimate
AdooQ BioScience leadership team
Management profileNumber of profiles
AdooQ BioScience funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AdooQ BioScience M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AdooQ BioScience
What does AdooQ BioScience do?
AdooQ BioScience manufactures and distributes a catalog of more than 60,000 high-purity research biochemicals, including inhibitors, chemical probes, and reference compounds organized by signaling pathway. The company sells these products directly to research scientists and institutions through its e-commerce platform at adooq.com, with global distribution and multi-currency checkout. The portfolio extends to PROTACs, antibody-drug conjugates, recombinant proteins, peptides, dyes, click chemistry reagents, isotope-labeled compounds, nanobodies, CRISPR reagents, and screening libraries used in academic and pharmaceutical drug discovery research.
Is AdooQ BioScience a public or private company?
AdooQ BioScience is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was AdooQ BioScience founded?
AdooQ BioScience was founded in 2006. It employs 51 to 100 people.
Where is AdooQ BioScience based?
AdooQ BioScience is headquartered in Irvine, United States, in the North America region.
How does AdooQ BioScience make money?
One revenue line is on record: research Biochemical Products.
Who are AdooQ BioScience's main competitors?
Direct peers on record are Santa Cruz Biotechnology, Cayman Chemical, MedChemExpress (MCE), Tocris Bioscience (Bio-Techne), TargetMol Chemicals, APExBIO, Enzo Life Sciences and Selleck Chemicals. Broad incumbents are Sigma-Aldrich (MilliporeSigma / Merck KGaA) and Bio-Techne.
Does AdooQ BioScience have an API?
No public API is recorded for AdooQ BioScience.
What industry is AdooQ BioScience in?
AdooQ BioScience's product category is Life Science Research Biochemicals. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAAAAAE, Antibody-Drug Conjugates (ADCs) & Antibody Conjugates. Its NAICS code is 325411 and its SIC code is 2833.